# EDGAR Filing Document

**Accession Number:** 0001803407
**File Stem:** 0001213900-26-002527
**Filing Date:** 2026-1
**Character Count:** 16657
**Document Hash:** b89bd504cb055bde03413446e4bc42f9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-002527.hdr.sgml**: 20260108

**ACCESSION NUMBER**: 0001213900-26-002527

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260108

**FILED AS OF DATE**: 20260108

**DATE AS OF CHANGE**: 20260108

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Ostin Technology Group Co., Ltd.
- **CENTRAL INDEX KEY:** 0001803407
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTRONIC COMPONENTS, NEC [3679]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41362
- **FILM NUMBER:** 26519786

**BUSINESS ADDRESS:**
- **STREET 1:** ROOM 101 BUILDING 2 KECHUANG ROAD 1
- **STREET 2:** QIXIA DISTRICT
- **CITY:** NANJIANG JIANGSU
- **STATE:** F4
- **ZIP:** 231300
- **BUSINESS PHONE:** 8602558595234

**MAIL ADDRESS:**
- **STREET 1:** ROOM 101 BUILDING 2 KECHUANG ROAD 1
- **STREET 2:** QIXIA DISTRICT
- **CITY:** NANJIANG JIANGSU
- **STATE:** F4
- **ZIP:** 231300

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER**

**PURSUANT TO RULE 13a-16 OR 15d-16**

**UNDER THE SECURITIES EXCHANGE ACT OF 1934**

**For the month of December 2025**

**Commission File Number: 001-41362**

**<u>Ostin Technology Group Co., Ltd.</u>**

**(Translation of registrant's name into English)**

**Building 2, 101**

**1 Kechuang Road**

**Qixia District, Nanjing**

**Jiangsu Province, China 210046**

**(Address of principal executive offices)**

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

**Appointment of Director**

On December 22, 2025, the board of directors of the Company (the "**Board**") approved the appointment of Mr. Rongguo Cui, age 62, as an independent director of the Company, effective immediately. Pursuant to an Independent Director Agreement (the "**Agreement**") dated December 22, 2025, entered between Mr. Cui and the Company, Mr. Cui shall hold the position for a term of three (3) years commencing as of the date of the Agreement, subject to early termination pursuant to terms of the Agreement. Pursuant to the Agreement. Mr. Cui will receive compensation of US$5,000 per quarter for his membership on the Board. The Agreement imposes certain duties and customary confidentiality obligations on Mr. Cui customary for the agreements of this nature. The foregoing description is merely a summary of the Agreement and therefore does not purport to be complete and the Agreement is qualified in its entirety by reference to the complete text of the Agreement, which is filed hereto as Exhibit 10.1.

Mr. Cui will be a member of the Audit Committee, the Compensation Committee, and the Nominating and Corporate Governance Committee, and will serve as chair of the Compensation Committee. In addition, Mr. Cui will serve on the special committee established by the Board, which is comprised solely of independent directors and was formed to investigate and oversee matters related to the United States Department of Justice ("**DOJ**") indictment and associated Nasdaq Stock Market LLC (the "**Nasdaq**") and regulatory inquiries.

The Board assessed the independence of Mr. Cui under the Company's corporate governance guidelines and the independence standards under the rules of the Nasdaq and has determined that Mr. Cui is independent.

Mr. Cui does not have any "family relationship" as defined in Item 401 of Regulation S-K. There is no arrangement or understanding, pursuant to which Mr. Cui was appointed as director of the Company. Mr. Cui is not related to any existing officer or director of the Company. There are also no transactions or relationships between or among Mr. Cui with the Company that would be required to be reported under Item 404(a) of Regulation S-K.

The biographical information of Mr. Cui is set forth below.

Mr. Cui has served as Co-Founder, Chairman and Chief Executive Officer of PI Semiconductor (Shenzhen) Co., Ltd since December 2020. He co-founded PI Semiconductor in 2019 and is responsible for corporate strategy. From April 2018 to November 2020, Mr. Cui served as Chief Executive Officer of NeuSemi Group Co., Ltd, where he led brand development, long-term growth strategy, and integration of several acquired entities. From August 2015 to March 2018, Mr. Cui served as Senior Director of Strategic Marketing and Business Development at Semtech Corporation, where he drove strategic initiatives for the company's communications business, including 5G, data center and broadband access applications. Mr. Cui received an MBA in Marketing and Finance from Oral Roberts University in 1996, an MA-equivalent degree in Applied Linguistics from the University of Chinese Academy of Sciences in 1987, and a bachelor's degree in English Literature from Jiangsu Normal University in 1985.

**Financial Statements and Exhibits.** 

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 10.1 | [Form of Independent Director Agreement between Ostin Technology Group Co., Ltd. and its director, Rongguo Cui,](ea027225001ex10-1_ostintec.htm) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | |
|:---|:---|
| **Ostin Technology Group Co., Ltd.** | **Ostin Technology Group Co., Ltd.** |
| By: | /s/ Tao Ling |
| Name: | Tao Ling |
| Title: | Chief Executive Officer |

---

Date: January 08, 2026

## Exhibit 10.1

**Exhibit 10.1**

**OSTIN TECHNOLOGY GROUP CO., LTD.**

**INDEPENDENT DIRECTOR AGREEMENT**

THIS AGREEMENT (The "**Agreement**") is made as of December [22th ], 2025 and is by and between Ostin Technology Group Co., Ltd., an exempted company incorporated with limited liability in the Cayman Islands (hereinafter referred to as the "**Company**"), and Rongguo Cui (hereinafter referred to as the "**Director**").

**BACKGROUND**

Following the nomination and recommendation of the Nominating and Corporate Governance Committee of the Board of Directors, the Board desires to appoint the Director, Mr. Rongguo Cui, as an independent director of the Company and to have the Director perform the duties of an independent director, and the Director desires to be so appointed for such position and to perform the duties required of such position in accordance with the terms and conditions of this Agreement.

**AGREEMENT**

In consideration for the above recited promises and the mutual promises contained herein, the adequacy and sufficiency of which are hereby acknowledged, the Company and the Director hereby agree as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1. DUTIES**. The Company requires that the Director be available to perform the duties of an independent director customarily related to this function as may be determined and assigned by the Board of Directors of the Company and as may be required by the Company's constitutional documents, including its memorandum and articles of association and its corporate governance and board committee charters, each as amended or modified from time to time, and by applicable law, including by the Companies Act (As Revised) of the Cayman Islands (the "**Cayman Companies Act**") . The Director agrees to devote as much time as is necessary to perform completely the duties as the Director of the Company, including duties as a member of the Compensation Committee, Nominating and Corporate Governance Committee, Audit Committee and such other committees as the Director may hereafter be appointed to. The Director will perform such duties described herein in accordance with the general fiduciary duty of directors arising under the Cayman Companies Act.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2. TERM**. Subject to Article 7 below, the term of this Agreement shall be [three] years commencing as of the date of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**3. COMPENSATION**. For all services to be rendered by the Director in any capacity hereunder, the Company agrees to pay the Director a fee of US$5,000 per quarter. Such fee may be adjusted from time to time as agreed by the parties.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**4. EXPENSES**. In addition to the compensation provided in paragraph 3 hereof, the Company will reimburse the Director for pre- approved reasonable business related expenses incurred in good faith in the performance of the Director' s duties for the Company. Such payments shall be made by the Company upon submission by the Director of a signed statement itemizing the expenses incurred. Such statement shall be accompanied by sufficient documentary matter to support the expenditures.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5. CONFIDENTIALITY**. The Company and the Director each acknowledge that, in order for the intents and purposes of this Agreement to be accomplished, the Director shall necessarily be obtaining access to certain confidential information concerning the Company and its affairs, including, but not limited to business methods, information systems, financial data and strategic plans which are unique assets of the Company ("**Confidential Information**"). The Director covenants not to, either directly or indirectly, in any manner, utilize or disclose to any person, firm, corporation, association or other entity any Confidential Information.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**6. NON- COMPETE**. During the term of this Agreement (the "**Restricted Period**") , the Director shall not, directly or indirectly, (i) in any manner whatsoever engage in any capacity with any business competitive with the Company's current lines of business or any business then engaged in by the Company, any of its subsidiaries or any of its affiliates (the "**Company's Business**") for the Director's own benefit or for the benefit of any person or entity other than the Company or any subsidiary or affiliate; or (ii) have any interest as owner, sole proprietor, shareholder, partner, lender, director, officer, manager, employee, consultant, agent or otherwise in any business competitive with the Company's Business; <u>provided</u>, <u>however</u>, that the Director may hold, directly or indirectly, solely as an investment, not more than two percent (2 %) of the outstanding securities of any person or entity which are listed on any national securities exchange or regularly traded in the over- the- counter market notwithstanding the fact that such person or entity is engaged in a business competitive with the Company's Business. In addition, during the Restricted Period, the Director shall not develop any property for use in the Company's Business on behalf of any person or entity other than the Company, its subsidiaries and affiliates.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**7. TERMINATION**. With or without cause, the Company and the Director may each terminate this Agreement at any time upon ten (10) days written notice, and the Company shall be obligated to pay to the Director the compensation and expenses due up to the date of the termination. Nothing contained herein or omitted herefrom shall prevent the shareholder(s) of the Company from removing the Director with immediate effect at any time for any reason.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**8. INDEMNIFICATION** . The Company shall indemnify, defend and hold harmless the Director, to the full extent allowed by the law applicable to the Company, and as provided by, or granted pursuant to, the memorandum and articles of association of the Company, agreement (including, without limitation, the Indemnification Agreement executed herewith), vote of shareholders or disinterested directors or otherwise, both as to action in the Director's official capacity and as to action in another capacity while holding such office.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9. EFFECT OF WAIVER**. The waiver by either party of the breach of any provision of this Agreement shall not operate as or be construed as a waiver of any subsequent breach thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**10. NOTICE**. Any and all notices referred to herein shall be sufficient if furnished in writing at the addresses specified on the signature page hereto or, if to the Company, to the Company's address as specified in filings made by the Company with the U. S. Securities and Exchange Commission.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**11. GOVERNING LAW**. This Agreement shall be interpreted in accordance with, and the rights of the parties hereto shall be determined by, the laws of the State of New York without reference to that state's conflicts of laws principles.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**12. CLAWBACK PROVISIONS.** Notwithstanding any other provisions in this Agreement to the contrary, any incentive-based or other compensation paid to the Director under this Agreement or any other agreement or arrangement with the Company which is subject to recovery under any law, government regulation, or stock exchange listing requirement will be subject to such deductions and clawback as may be required to be made pursuant to such law, government regulation, or Nasdaq Stock Market listing requirement (or any policy adopted by the Company, including the Clawback Policy adopted by the Company on December 1, 2023, pursuant to any such law, government regulation or Nasdaq Stock Market requirement).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**13. ASSIGNMENT**. The rights and benefits of the Company under this Agreement shall be transferable, and all the covenants and agreements hereunder shall inure to the benefit of, and be enforceable by or against, its successors and assigns. The duties and obligations of the Director under this Agreement are personal and therefore the Director may not assign any right or duty under this Agreement without the prior written consent of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**14. MISCELLANEOUS**. If any provision of this Agreement shall be declared invalid or illegal, for any reason whatsoever, then, notwithstanding such invalidity or illegality, the remaining terms and provisions of the this Agreement shall remain in full force and effect in the same manner as if the invalid or illegal provision had not been contained herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**15. ARTICLE HEADINGS**. The article headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**16. COUNTERPARTS**. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one instrument. Facsimile execution and delivery of this Agreement is legal, valid and binding for all purposes.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**17. ENTIRE AGREEMENT**. Except as provided elsewhere herein, this Agreement sets forth the entire agreement of the parties with respect to its subject matter and supersedes all prior agreements, promises, covenants, arrangements, communications, representations or warranties, whether oral or written, by any officer, employee or representative of any party to this Agreement with respect to such subject matter.

[ *Signature Page Follows*]

IN WITNESS WHEREOF, the parties hereto have caused this Independent Director Agreement to be duly executed and signed as of the day and year first above written.

---

| | |
|:---|:---|
| **OSTIN TECHNOLOGY GROUP CO., LTD.** | **OSTIN TECHNOLOGY GROUP CO., LTD.** |
| By: | /s/ Tao Ling |
| Name: | Tao Ling |
| Title: | Chief Executive Officer and Chairman |

---

[*Signature Page to Independent Director Agreement*

---

| |
|:---|
| **INDEPENDENT DIRECTOR** |
| /s/ Rongguo Cui |
| Rongguo Cui |

---